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2. Abstract 27 
Purpose: We determined the effects of CWI on long-term adaptations and post-exercise 28 
molecular responses in skeletal muscle before and after resistance training. Methods: Sixteen 29 
males (22.9 ± 4.6 y; 85.1 ± 17.9 kg; mean ± SD) performed resistance training (3 dꞏwk-1) for 30 
7 wk, with each session followed by either CWI (15 min at 10°C, COLD group, n = 8) or 31 
passive recovery (15 min at 23°C, CON group, n = 8). Exercise performance [one-repetition 32 
maximum (1-RM) leg press and bench press, countermovement jump, squat jump and 33 
ballistic push-up], body composition (dual x-ray absorptiometry), and post-exercise (i.e., +1 34 
and +48 h) molecular responses were assessed before and after training. Results: 35 
Improvements in 1-RM leg press were similar between groups [130 ±69 kg, pooled effect 36 
size (ES): 1.53; ±90% confidence interval (CI) 0.49], while increases in type II muscle fiber 37 
cross-sectional area were attenuated with CWI (-1959 µM2; ±1675; ES: -1.37; ±0.99). Post-38 
exercise mTORC1 signalling (rps6 phosphorylation) was blunted for COLD at POST +1 h (-39 
0.4-fold, ES: -0.69; ±0.86) and POST +48 h (-0.2-fold, ES: -1.33; ±0.82), while basal protein 40 
degradation markers (FOX-O1 protein content) were increased (1.3-fold, ES: 2.17; ±2.22). 41 
Training-induced increases in HSP27 protein content were attenuated for COLD (-0.8-fold, 42 
ES, -0.94 ±0.82), which also reduced total HSP72 protein content (-0.7-fold, ES: -0.79, 43 
±0.57). Conclusion: CWI blunted resistance training-induced muscle fiber hypertrophy, but 44 
not maximal strength, potentially via reduced skeletal muscle protein anabolism and 45 
increased catabolism. Post-exercise CWI should therefore be avoided if muscle hypertrophy 46 
is desired. 47 
 48 
New and noteworthy: This study adds to existing evidence that post-exercise cold water 49 
immersion attenuates muscle fiber growth with resistance training, which is potentially 50 
mediated by attenuated post-exercise increases in markers of skeletal muscle anabolism 51 
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coupled with increased catabolism, and suggests blunted muscle fiber growth with cold water 52 
immersion does not necessarily translate to impaired strength development.  53 
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3. Introduction 54 
Cold water immersion (CWI) is a popular recovery technique aimed at limiting, and 55 
accelerating recovery from, short-term exercise-induced decrements in exercise performance 56 
(72). Reported benefits of CWI include faster recovery of muscle strength (4, 62, 69), muscle 57 
soreness (4, 32, 57, 66, 69), perceptions of fatigue (9, 48, 57, 65, 66), markers of 58 
inflammation (39, 50, 53, 65) and muscle damage (19, 62). Improved recovery from single 59 
exercise sessions, mediated by CWI, is theorized to improve long-term adaptations to 60 
exercise training by enhancing subsequent training load and/or quality (72). However, as 61 
some of the post-exercise effects purportedly blunted by CWI also stimulate exercise-induced 62 
adaptations (8), CWI may actually hinder exercise training adaptations in some 63 
circumstances. Indeed, regular post-exercise CWI during resistance training can attenuate 64 
improvements in both maximal strength and muscle mass (56, 77).  65 
 66 
Skeletal muscle hypertrophy consequent to resistance training is mediated by the dynamic 67 
changes in protein synthesis and breakdown stimulated by single exercise sessions (52, 55). 68 
Application of CWI in the post-exercise recovery period may influence post-exercise muscle 69 
protein synthesis and/or breakdown rates via a variety of mechanisms. For example, cold-70 
induced vasoconstriction reduces muscle blood flow (26, 37, 38), which is positively 71 
associated with post-exercise muscle protein synthesis (MPS) rates (23, 67). Increased MPS 72 
following exercise also appears partially dependent upon the post-exercise inflammatory 73 
response (68), which is blunted following CWI application according to some (39, 50, 53, 74 
65), but not all (51, 77), studies. As well as influencing MPS, animal studies suggest cold 75 




Any influence of CWI application on post-exercise MPS or breakdown is likely mediated via 78 
the molecular pathways governing these responses. Rates of MPS are controlled by the 79 
mechanistic target of rapamycin complex 1 (mTORC1) signalling pathway, which includes 80 
the downstream targets p70S6K (p70 kDa ribosomal protein subunit kinase 1) and 4E-BP1 81 
(eukaryotic initiation factor 4E binding protein 1) (25). Rates of muscle protein breakdown 82 
are primarily controlled via the ubiquitin proteasome pathway (24). Key members of this 83 
pathway include muscle-specific E3 ubiquitin ligases MuRF-1 (muscle RING finger-1) and 84 
MaFbx/Atrogin-1 (muscle atrophy F-box), and the FOX-O subfamily of transcription factors 85 
that include FOX-O1 and FOX-O3a (33, 60). Modulation of heat shock proteins (HSP) may 86 
also influence muscle mass regulation, since several HSPs interact with key components of 87 
the mTORC1 and ubiquitin proteasome pathways (1, 5, 15, 16, 35, 61, 71, 79), and may also 88 
stabilise disrupted muscle contractile elements and assist in post-exercise regeneration and 89 
remodelling (34, 49). 90 
 91 
Evidence has emerged suggesting CWI application after a single session of resistance 92 
exercise influences some of the molecular responses mediating hypertrophic adaptation in 93 
human skeletal muscle. In one study (56), CWI (10 min at 10°C) attenuated post-exercise 94 
mTORC1 signalling (specifically, p70S6K phosphorylation) and satellite cell activation after 95 
a single session of lower-body resistance training. Conversely, the expression and localisation 96 
of HSP72 and αβ-crystallin were unchanged by CWI (51). Continuing this protocol for 12 97 
weeks blunted the increases in type II muscle fiber cross-sectional area (CSA), myonuclear 98 
accretion, and one-repetition maximum (1-RM) leg press and leg extension strength (56). 99 
These data suggest the negative effects of CWI on resistance training adaptations may be 100 
underpinned by modulation of the early post-exercise anabolic profile in skeletal muscle. 101 
Whether CWI also influences post-exercise markers of protein degradation in human skeletal 102 
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muscle has, however, not been investigated. Moreover, since post-exercise molecular 103 
responses are modulated by periods of training (73, 76), it is unclear whether the influence of 104 
CWI on these responses are attenuated over time, which has implications for longer-term 105 
effects on training adaptation. 106 
 107 
The inherent limitations of existing evidence showing attenuated resistance training 108 
adaptations with CWI may also compromise the applicability of their findings to athletic 109 
populations. For example, some studies have applied CWI to only a single limb (3, 22, 30, 110 
31, 47, 77, 78), and/or used training protocols incorporating either a single exercise (22, 47, 111 
77, 78) or lower-body exercises only (56), all of which are uncommon training practices. We 112 
therefore aimed to examine whether post-exercise CWI application modulates key 113 
adaptations following seven weeks of whole-body resistance training. In addition, we 114 
investigated the effects of CWI on post-exercise anabolic and catabolic molecular responses 115 
to a single session of whole-body resistance training, and compared these responses before 116 
and after the training intervention.   117 
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4. Methodology 118 
Participants 119 
Sixteen recreationally-active males (see Table 1 for participant characteristics) who had not 120 
been involved in regular resistance training for at least six months completed the study. 121 
Participants were fully informed of the study procedures, screened for cardiovascular or 122 
musculoskeletal conditions, and gave written informed consent before participation. All 123 
protocols and procedures were approved by the Human Research Ethics Committee at 124 
Victoria University and conformed to the Declaration of Helsinki. 125 
 126 
***INSERT TABLE 1 ABOUT HERE*** 127 
 128 
Study overview 129 
An overview of the study procedures is shown in Figure 1. Before preliminary testing, 130 
participants were familiarized with all performance assessments, including leg press one-131 
repetition maximum (1-RM), bench press 1-RM, and ballistic exercise performance [counter-132 
movement jump (CMJ), squat jump, and ballistic push-up] tests. Participants were also 133 
familiarized with all resistance training exercises to ensure appropriate technique and to 134 
determine loads for their first training session. One week following the familiarisation 135 
session, participants underwent a dual energy x-ray absorptiometry (DXA) scan and repeated 136 
the performance assessments, which served as pre-training (PRE) data. After preliminary 137 
testing, participants were pair-matched for leg press 1-RM, and one of each pair was 138 
randomly allocated to either the CWI (COLD; n = 8) or control (CON; n = 8) groups. At least 139 
72 h after preliminary testing, participants performed a biopsy trial that doubled as the first 140 
session of a seven-week, whole-body, resistance training program. Post-training performance 141 
tests (POST) were performed during the last training session, followed by a second DXA 142 





Figure 1. Study overview. DXA, dual x-ray absorptiometry scan; BEP, ballistic exercise 146 
performance (countermovement jump, squat jump, ballistic push-up) testing; 1-RM, one-147 
repetition maximum (leg press and bench press) testing. 148 
 149 
***INSERT FIGURE 1 ABOUT HERE*** 150 
 151 
Ballistic exercise performance 152 
Countermovement jump (CMJ) performance 153 
Before testing, participants performed a warm-up consisting of 5 min of stationary cycling at 154 
1W/kg body mass. Countermovement jump (CMJ) performance was assessed using a force 155 
plate (Fitness Technology, Skye, SA). Jumps began from a standing starting position, with 156 
the feet approximately shoulder-width apart and hands placed on the hips throughout. 157 
Participants then lowered themselves to a self-selected depth and jumped for maximal height 158 
without pausing between the eccentric and concentric phases. Participants were encouraged 159 
to be as explosive as possible during the movement to achieve maximal jump height. Three 160 
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maximal CMJs were performed by each participant, with one min of rest between each jump. 161 
The jump whereby the highest peak force was achieved was chosen for analysis. 162 
 163 
Squat jump performance 164 
Squat jump performance was assessed in the same manner as for CMJ; however, participants 165 
were required to remain static in the bottom position of the jump for 3 s before performing 166 
the concentric phase of the jump. The jump whereby the highest peak force was achieved was 167 
chosen for analysis. 168 
 169 
Ballistic push-up performance 170 
Participants adopted a push-up position with their hands in the centre of the force plate and 171 
elbows at full extension. They then lowered themselves to 90° elbow flexion, remained static 172 
for 2 s, and then pushed up as explosively as possible to achieve maximal height from the 173 
force plate. Participants were required to keep their body straight throughout the procedure. 174 
The trial whereby the highest peak force was achieved was chosen for analysis. 175 
 176 
Maximal strength  177 
Maximal strength was assessed via one-repetition maximum (1-RM) leg press and bench 178 
press exercises using a plate-loaded 45° incline leg press (Hammer Strength Linear, Schiller 179 
Park, IL) and standard bench press, respectively. Following a standardized warm-up of 6, 4 180 
and 2 repetitions at 50, 70 and 90% estimated 1-RM, respectively, single repetitions of 181 
increasing load were attempted until the maximal load for one repetition was determined. 182 
Three minutes of recovery was given between attempts. Leg press repetitions began with the 183 
knee fully extended and the heel placed at the bottom edge of the foot plate. The foot plate 184 
was lowered until the knee angle reached 90° and was then returned to full extension. Bench 185 
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press repetitions started from full elbow extension, after which the barbell was lowered to the 186 
chest and then lifted to full elbow extension. 187 
 188 
Body composition 189 
Body composition was assessed via Dual X-ray Absorptiometry (DXA) (Discovery W, 190 
Hologic Inc.,Bedford, MA) both pre- and post-training. Participants were scanned in the 191 
fasted state and were instructed not to perform any exercise for 12 h prior to each scan. The 192 
scanner was calibrated daily, and the same certified densitometry technician performed and 193 
analysed both the pre- and post-training scans for each participant. 194 
 195 
Resistance training (RT) intervention 196 
The resistance training (RT) program was performed three times per week on non-197 
consecutive days (see Table 2), for seven weeks. Training intensity was set at 12-RM for all 198 
exercises except for dips and abdominal curls, which were set at 20-RM. Once a participant 199 
could perform all sets of a particular exercise at the target number of repetitions at the 200 
prescribed load, the load for that exercise was then increased by ~5% for the next session. 201 
Two minutes of recovery was allowed between sets. At the start of the third session for each 202 
week, both leg press and bench press 1-RM were assessed (as described previously). 203 
 204 
***INSERT TABLE 2 ABOUT HERE*** 205 
 206 
Recovery interventions 207 
Five minutes after completing each RT session, participants underwent their assigned 208 
recovery intervention for 15 min. Participants in the COLD group were seated (with legs 209 
fully extended) in an inflatable bath (iBody, iCool Sport, Australia), and immersed in water 210 
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up to their sternum. Water temperature was maintained at 10°C with a cooling/heating unit 211 
(Dual Temp Unit, iCool Sport, Australia). Participants in the CON group instead sat in a chair 212 
in a room maintained at 23°C for the 15 min period. 213 
 214 
Muscle biopsy trial 215 
Participants were asked to refrain from exercise and alcohol in the 24 h preceding the muscle 216 
biopsy trial, and reported to the lab in a fasted state after ingesting a standardized dinner 217 
(containing 53.1 g carbohydrate, 41 g protein and 10.9 g fat) the night before. After sitting 218 
quietly for ~10 min, a resting vastus lateralis muscle biopsy was taken (described below). 219 
Participants rested for a further 10 min before performing the first session of their RT 220 
program, followed by their allocated recovery intervention. Participants then rested for 1 h 221 
before a second muscle biopsy was taken. Participants were then given a post-exercise snack 222 
(containing 61.2 g carbohydrate, 13.2 g protein and 13.4 g fat) before leaving the laboratory. 223 
Participants returned to the laboratory for a third biopsy sample 48 h after completing the 224 
exercise session. Participants were also asked to refrain from exercise and alcohol in the 24 h 225 
preceding this biopsy and reported to the lab in a fasted state following a standardized dinner 226 
(equivalent to the pre-trial dinner) the night before. The biopsy trial was repeated 72 to 96 h 227 
after the final resistance training session. 228 
 229 
Muscle biopsy procedure 230 
During the pre- and post-training biopsy trials, a needle muscle biopsy was taken from the 231 
middle third of the vastus lateralis muscle at rest, and 1 and 48 h after exercise. After 232 
injection of a local anaesthetic into the skin and fascia [1% lidocaine (xylocaine)], a small 233 
incision was made and a muscle sample taken using a Stille biopsy needle modified with 234 
suction (20). Each biopsy was taken from the participant’s dominant leg via a separate 235 
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incision, 1 to 2 cm proximal from the previous biopsy. Muscle samples were blotted on filter 236 
paper to remove excess blood, immediately frozen in liquid nitrogen, and stored at −80 °C 237 
until subsequent analysis. A small portion of each biopsy sample (~20 mg) was embedded in 238 
Tissue-Tek (Sakura, Finetek, NL), frozen in liquid nitrogen-cooled isopentane, and stored at 239 
−80 °C for subsequent immunofluorescence analysis. 240 
 241 
Muscle temperature assessment 242 
Muscle temperature responses to the exercise and recovery protocols were assessed 243 
immediately following the fourth session of the RT program. This session was chosen as it 244 
involved the same RT protocol as the muscle biopsy trial, thereby providing a representation 245 
of muscle temperature responses during this trial, while limiting the number of invasive 246 
measures obtained. Immediately after completion of the RT protocol, a thermistor was 247 
inserted at a site ~5 cm lateral to the mid-point between the participant’s anterior superior 248 
iliac spine and head of the patella, on the dominant leg (9). An 18 gauge needle (Optiva IV 249 
Catheter 18GX1.75", Smiths Medical, USA) was inserted at the marked site, after which it 250 
was subsequently removed whilst leaving the catheter in the quadriceps muscle. A needle 251 
thermistor probe (Model T-204A, Physitemp Instruments, USA) was inserted through the 252 
catheter, to a depth of ~4 cm below the skin. The thermistor probe and catheter were securely 253 
covered and fastened to the leg, allowing for movement and continual measurement (2 Hz) of 254 
muscle temperature during the recovery intervention. 255 
 256 
Immunohistochemistry 257 
Muscle cross-sections (10 µM) were cut at -20°C using a cryostat (CM 1950, Leica 258 
Biosystems, Buffalo Grove, IL), mounted on uncoated glass slides, and frozen at -80°C until 259 
subsequent analysis. After thawing for 10 min at room temperature, sections were rinsed 260 
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briefly with 1×PBS (phosphate buffered saline; 0.1M; Sigma Aldrich, St Louis, MO), fixed 261 
with cold paraformaldehyde (4% v/v in 1×PBS) for 10 min at room temperature, rinsed three 262 
times with 1×PBS, and then blocked for 1 h at room temperature in a 3% w/v BSA solution 263 
in 1×PBS. After blocking, sections were then incubated with a primary antibody for myosin 264 
heavy chain type I (cat no. M8421, Sigma Aldrich, St Louis, MO), diluted 1:25 in 3% w/v 265 
BSA/PBS, for 2 h at room temperature. Slides were then washed three times in 1×PBS for 5 266 
min each before incubation with a secondary antibody (Alexa Fluor® 568 conjugate Goat 267 
anti-mouse IgG1, cat. no. A-21124, Thermo Fisher Scientific, Waltham, MA) diluted 1:500 268 
in 3% w/v BSA/PBS for 1 h in the dark at room temperature. Sections were again washed 269 
three times in 1×PBS for 5 min each, before incubation with Wheat Germ Agglutinin (WGA) 270 
(Alexa Fluor® 488 Conjugate; cat. no. W11261, Thermo Fisher Scientific, Waltham, MA), 271 
diluted to 1:100 in 1×PBS (from a 1.25 mg/mL stock solution), for 15 min at room 272 
temperature. Sections were washed again twice with 1×PBS for 3 min each, blotted dry with 273 
a Kim-Wipe, and anti-fade solution (ProlongTM Gold AntiFade Mountant; cat. no. P36930; 274 
Thermo Fisher Scientific, Waltham, MA) added to each section before the coverslip was 275 
mounted. Stained muscle sections were air-dried overnight and viewed with a confocal 276 
microscope (Olympus FV10i, Shinjuku, Japan). Images were captured with a 10× objective 277 
and analysed using MyoVision Basic software (version 1.0) (74). Analysis was completed by 278 
an investigator blinded to all groups and time points. For each subject, muscle fiber CSA was 279 
determined for both type I and type II muscle fibers. For the COLD and CON groups, a total 280 
of 59 ± 19, and 50 ± 24 (mean ± SD) type I fibers and 87 ± 40, and 75 ± 42 (mean ± SD) type 281 
II fibers were analysed per subject (and per timepoint), respectively. Representative 282 
immunohistochemistry images for both training groups at pre- and post-training are shown in 283 





Western blotting 287 
The abundance of target proteins in muscle samples were determined with all constituents 288 
present (i.e., without centrifugation) (42). Frozen muscle was cut into 20 µm sections 289 
(Cryostat HM550, Thermo Scientific, Australia), and approximately 20 sections were 290 
dissolved in 200 µL homogenising buffer [125 mM Tris-HCl, 4% SDS, 10% Glycerol, 10 291 
mM EGTA, 100 mM DTT, with 0.1 % v/v protease and phosphatase inhibitor cocktail 292 
(#P8340 and #P5726, Sigma Aldrich, Castle Hill, NSW, Australia)], which were vortexed 293 
and then freeze-thawed. The protein concentration of each sample was then determined using 294 
a commercially-available assay with SDS neutralizer (Red 660, G-Biosciences, Astral 295 
Scientific, Gymea NSW, Australia) and samples were diluted to equivalent concentrations (1 296 
µgꞏµL-1) in homogenising buffer. Bromophenol blue (1% v/v) was added to samples and 297 
pooled samples, and aliquots of each sample were made to avoid multiple freeze-thaw cycles. 298 
Samples were heated at 95 °C for 5 min before 6 to 8 µg protein was loaded per lane into pre-299 
cast 26-well 4 to 20% gradient gels (Criterion™ TGX Stain-Free™ Precast, BioRad, 300 
Gladesville NSW, Australia). A molecular weight ladder (PageRuler® Plus, Thermo 301 
Scientific, Australia) and a five-point calibration curve (4 to 24 µg) consisting of a pooled 302 
sample were also loaded on each gel to allow direct comparison of blot intensities via linear 303 
regression (42). Samples from both the CON and CWI groups were loaded into each gel. 304 
Optimal loading volumes were determined for each protein target to ensure that blot 305 
intensities were within the linear range of the standard curve (i.e., to avoid primary antibody 306 
saturation) (42). After separation by SDS PAGE, stain-free gels were activated by UV light 307 
(ChemiDoc™ MP, BioRad, Gladesville NSW, Australia) and imaged prior to antibody 308 
incubation to visualise the total protein of each lane, both for confirmation of sample loading 309 
and for subsequent loading control normalisation. Proteins were then transferred to PVDF 310 
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membranes (Trans-Blot® Turbo™, BioRad, Gladesville NSW, Australia), which were then 311 
blocked in 20 mM Tris, 150 mM NaCl, and 0.1% Tween 20 (TBST) containing 5% nonfat 312 
milk for 1 h at room temperature, washed with TBST, and then incubated with primary 313 
antibody overnight at 4ºC. To determine protein expression and phosphorylation, membranes 314 
were incubated with the following antibodies diluted 1:1000 in TBST containing 5% w/v 315 
BSA and 0.1% w/v sodium azide. Primary antibodies for phosphorylated (p-) p-mTORSer2448 316 
(#5536), mTOR (#2972), p-p70S6K1Thr389 (#9234), p70S6K1 (#2708), p-4E-BP1Thr37/46 317 
(#2855), 4E-BP1 (#9644), p-rps6Ser235/236 (#2211), rps6 (#2217), p-FOXO1Ser256 (#9461), 318 
FOXO1 (#2880), p-FOXO3aSer253 (#13129), and FOXO3a (#12829) were from Cell 319 
Signalling Technology (Danvers, MA), p-HSP27Ser82 (#ALX-804-588), p-HSP27Ser15 (#ADI-320 
SPA-525), HSP27 (#ADI-SPA-800), p-αB-crystallinSer59 (#ADI-SPA-227), αβ-crystallin 321 
(#ADI-SPA-222), HSP72 (#ADI-SPA-810) was from Enzo Life Sciences (Farmingdale, NY), 322 
and MuRF1 (#MP3401) was from ECM Biosciences (Versailles, KY). Membranes were 323 
washed 5 times with TBST, before probing with appropriate horseradish peroxidase-324 
conjugated secondary antibody (PerkinElmer, Glen Waverley, Victoria, Australia), at a 325 
dilution of 1:50,000 – 100,000 in 5% non-fat milk TBST for 1 h at room temperature. 326 
Protein-antibody-HRP conjugates were incubated in ECL (SuperSignal® West Femto, 327 
Thermo Scientific, Australia) and imaged with a high sensitivity CCD camera (ChemiDoc™ 328 
MP, BioRad, Gladesville NSW, Australia) for subsequent analysis (ImageLab v 5.1, BioRad, 329 
Gladesville NSW, Australia). Total protein loading of each sample was determined from 330 
stain-free images of each gel, and these values were then used to normalise each protein of 331 
interest after normalisation to its respective standard curve. Representative western blot 332 
images for each measured protein are shown in Figure 6. 333 
 334 
Statistical analyses 335 
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To reduce bias from non-uniformity of error, heteroscedastic data were logarithmically 336 
transformed before analysis (e.g., for Western blot data) (45). For these data, geometric mean 337 
and SD (geometric mean × / ÷ SD) are reported. All other data are reported as mean ± SD 338 
unless otherwise specified. Linear mixed models were used to determine the influence of 339 
recovery condition (i.e., COLD or CON) on outcome variables, with “time” (repeated 340 
measure across all timepoints), “training status” (i.e., pre- vs. post-training), “group” and 341 
“group × time” as fixed factors, and “subject” as a random factor. First-order autoregressive 342 
covariance structures were used for all models, and model fit was assessed by –2 log 343 
likelihood (21). In the absence of a statistically significant (P < 0.05) group × time 344 
interaction, effects over time are reported on pooled group data (i.e., for both groups 345 
combined). The magnitude of within-group changes in dependent variables (and between-346 
group differences in these changes) were quantified as Cohen’s d (effect size, ES), applying 347 
thresholds of < 0.2 = trivial, 0.2-0.6 = small, 0.6-1.2 = moderate, 1.2-2.0 = large, 2.0-4.0 = 348 
very large and > 4.0 = extremely large (29). Effects were considered substantial if there was a 349 
>75% probability of being positive relative to the smallest worthwhile change (ES = 0.2), and 350 
effects with a >5% probability of being either substantially positive or negative were deemed 351 
unclear (29). Uncertainty of effects were determined as 90% confidence intervals (CI) and 352 
precise P values (unless P < 0.001) (13). Linear mixed models were analysed using IBM 353 
SPSS Statistics Version 25 (IBM, Somers, NY) and ES and CI values were determined via 354 
custom Excel spreadsheets (28). Percent compliance between groups was compared using an 355 
independent samples t-test (IBM SPSS Statistics Version 25, Somers, NY) and ES and CI 356 
values were determined using a custom Excel spreadsheet (27). 357 
 358 
  359 
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5. Results 360 
For a detailed summary of statistical data for all within- and between-group effects 361 
considered substantial in magnitude, see Tables 3 and 4, respectively. 362 
 363 
Training compliance 364 
Training compliance was not different between CON (92.3 ± 6.2%) and COLD (91.1 ± 4.7%) 365 
(P = 0.676, ES: 0.20; ±90% CI 0.83). 366 
 367 
Muscle temperature assessment 368 
Between the completion of the fourth training session and end of the post-exercise recovery 369 
intervention, muscle temperature decreased more for COLD (-3.5°C ± 3.5) vs. CON (-0.5°C ± 370 
0.5) (group × time interaction: P = 0.031, ES: 2.27; ±1.27). 371 
 372 
Basal responses to training 373 
Performance measures 374 
Maximal strength 375 
There was no group × time interaction (P = 0.959, ES: 0.04; ±0.78) for one-repetition 376 
maximum (1-RM) leg press (Table 2), which increased at POST for both groups combined 377 
(time main effect: P < 0.001, Table 3).  378 
 379 
Similar to lower-body strength, there was no group × time interaction (P = 0.582, ES: 0.08; 380 
±0.35) for 1-RM bench press (Table 2), which increased at POST for both groups combined 381 





Countermovement jump (CMJ), squat jump, and ballistic push-up performance  385 
There was a group × time interaction (P = 0.006) for peak CMJ force (Table 2), which 386 
increased at POST only for CON (Table 3) and with a greater change vs. COLD (Table 4). 387 
 388 
There was no group × time interaction for neither peak squat jump force (P = 0.249, ES: 389 
0.33; ±0.51) nor ballistic push-up force (P = 0.898, ES: 0.05; ±0.30), neither of which 390 
changed over time for both groups combined (time main effect: P = 0.355, ES: 0.13; ±0.36 391 
and P = 0.898, ES: 0.03; ±0.23, respectively, see Table 2). 392 
 393 
Body composition 394 
There was no group × time interaction (P = 0.867, ES: 0.02; ±0.22) for total lean mass (Table 395 
2), which increased at POST for both groups combined (time main effect: P < 0.001, Table 396 
3). 397 
 398 
There was no group × time interaction for lower-body lean mass (P = 0.935, ES: 0.22; ±0.37) 399 
or upper-body lean mass (P = 0.669, ES: 0.06; ±0.30, Table 2). For both groups combined, 400 
both lower-body and upper-body lean mass were increased at POST (time main effect: P = 401 
0.002 and P < 0.001, respectively, Table 3). 402 
 403 
There was no group × time interaction (P = 0.423, ES: 0.09; ±0.15) for fat mass (Table 2), 404 
which decreased at POST for both groups combined (time main effect: P = 0.005, Table 3).  405 
 406 
Muscle fiber CSA 407 
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There was no group × time interaction (P = 0.568, ES: 0.52; ±1.38) for type I muscle fiber 408 
CSA (Figure 2A), which was unchanged at POST for both groups combined (time main 409 
effect: P = 0.175, ES: 0.42; ±0.92). 410 
There was no group × time interaction (P = 0.062) for type II muscle fiber CSA (Figure 2B); 411 
however, there was a greater PRE-POST change for CON vs. COLD (Table 4). 412 
Representative immunohistochemical images for changes in muscle fiber CSA are shown in 413 
Figure 2 (C-F). 414 
 415 
***INSERT TABLE 3 ABOUT HERE*** 416 
 417 





Figure 2. Type I (A) and type II (B) muscle fiber cross-sectional area (CSA) before (PRE), 421 
and after (POST) seven weeks of resistance training with either cold-water immersion 422 
(COLD) or passive control (CON) applied after each training session. Data are mean values ± 423 
SD. 424 
 425 
Representative confocal microscope immunofluorescence images of muscle cross-sections 426 
obtained before (PRE) and after (POST) seven weeks of resistance training with application 427 
of either control (CON; images C and D, respectively) or cold-water immersion (COLD; 428 
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images E and F, respectively) or after each training session. Muscle fiber membranes are 429 
visualized green, type I muscle fibers are visualized red, and type II muscle fibers are 430 
unstained. Scale bar = 200 µm. 431 
† = Substantially greater change for CON vs. COLD. 432 
 433 
 434 
***INSERT FIGURE 2 ABOUT HERE*** 435 
 436 
Total protein content 437 
Total p70S6K protein 438 
There was no group × time interaction (P = 0.152, ES: 0.67, ±0.70) for total p70S6K protein 439 
(Figure 3B), which was unchanged at POST for both groups combined (time main effect: P = 440 
0.888, ES: 0.03; ±0.74).  441 
 442 
Total rps6 protein 443 
There was no group × time interaction (P = 0.577, ES: 0.51, ±1.33) for total rps6 protein 444 
(Figure 3D), which increased at POST for both groups combined (time main effect: P = 445 
0.009, Table 3). 446 
 447 
Total 4E-BP1 protein 448 
There was no group × time interaction (P = 0.128, ES: 0.33, ±0.43) nor main effect of time (P 449 
= 0.061, ES: 0.26; ±0.35) for total 4E-BP1 protein (Figure 3F). 450 
 451 
Total FOX-O1 protein 452 
There was no group × time interaction (P = 0.108) for total FOX-O1 protein (Figure 4B), 453 
which increased at POST for both groups combined (time main effect: P = 0.007, Table 3). 454 
There was, however, a greater PRE-POST change in total FOX-O1 protein for COLD vs. 455 
CON (Table 4). 456 
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Total FOX-O3a protein 457 
There was no group × time interaction (P = 0.644, ES: 1.50, ±1.97) for total FOX-O3a 458 
protein (Figure 4D), which was unchanged at POST for both groups combined (time main 459 
effect: P = 0.195, ES: 0.54; ±1.34). 460 
 461 
Total MuRF-1 protein 462 
There was no group × time interaction (P = 0.596, ES: 0.10, ±0.36) for total MuRF-1 protein 463 
(Figure 4E), which was unchanged at POST for both groups combined (time main effect: P = 464 
0.313, ES: 0.10, ±0.25). 465 
 466 
Total HSP27 protein 467 
There was no group × time interaction (P = 0.113) for total HSP27 protein (Figure 5B), 468 
which increased at POST for both groups combined (time main effect: P < 0.001, Table 3), 469 
with a greater PRE-POST change for CON vs. COLD (Table 4). 470 
 471 
Total HSP72 protein 472 
There was no group × time interaction (P = 0.465) for total HSP72 protein (Figure 5D), 473 
which decreased at POST for both groups combined (time main effect: P < 0.013, Table 3), 474 
due to a reduction for COLD (Table 3) and not for CON (-0.8-fold × / ÷ 1.4, ES: -0.33, 475 
±0.65).  476 
 477 
Total αβ crystallin protein 478 
There was no group × time interaction (P = 0.488, ES: 0.29, ±0.88) for total αβ crystallin 479 
protein (Figure 5F), which increased at POST for both groups combined (time main effect: P 480 




Responses to single exercise sessions before and after training 483 
mTORC1 signalling responses 484 
p-p70S6K Thr389 485 
There was no group × time interaction (P = 0.411), nor influence of training status (P = 486 
0.369), for p70S6KThr389 phosphorylation (Figure 3A). p70S6KThr389 phosphorylation  was, 487 
however, increased for both groups combined at PRE +1 h, PRE +48 h, and POST +48 h 488 
(time main effect: P = 0.001, Table 3). 489 
 490 
p-rps6 Ser235/236 491 
There was no group × time interaction (P = 0.154), nor influence of training status (P = 492 
0.707), for rps6Ser235/236 phosphorylation (Figure 3C), which was increased for both groups 493 
combined at PRE +1 h, POST +1 h, and POST +48 h (time main effect: P < 0.001, Table 3). 494 
There were also greater increases in rps6Ser235/236 phosphorylation for CON vs. COLD at both 495 
POST +1 h and POST +48 h (Table 4). 496 
 497 
p-4E-BP1 Thr36/47 498 
There was no group × time interaction (P = 0.440) nor main effects of training status (P = 499 
0.94) or time (P = 0.395) for 4E-BP1Thr36/47 phosphorylation (Figure 3E). There was, 500 
however, a greater increase in 4E-BP1Thr36/47 phosphorylation for CON vs. COLD from PRE-501 






Figure 3. mTORC1 signalling responses. Phosphorylation and total proteins levels of 506 
p70S6KThr389 (A, B respectively), rps6Ser235/236 (C, D respectively), and 4E-BP1Thr36/47 (E, F 507 
respectively) before (PRE) and after (POST) seven weeks of resistance training with either 508 
cold-water immersion (COLD) or passive control (CON) applied after each training session, 509 
as well as 1 h and 48 h after single exercise bouts performed before (PRE +1 h, PRE +48 h) 510 
and after (POST +1 h, POST +48 h) the training period (phosphorylated proteins only). Data 511 
shown are back-transformed individual participant values and geometric means. 512 





***INSERT FIGURE 3 ABOUT HERE*** 516 
 517 
 518 
Protein degradation responses 519 
p-FOX-O1 Ser256 520 
There was no group × time interaction (P = 0.311) nor influence of training status (P = 0.202) 521 
for FOX-O1Ser256 phosphorylation (Figure 4A), which was unchanged over time for both 522 
groups combined (P = 0.302). There was, however, a greater increase for CON vs. COLD at 523 
both POST +1 h and POST +48 h (Table 4). 524 
 525 
p-FOX-O3a Ser253 526 
There was no group × time interaction (P = 0.414) nor influence of training status (P = 0.688) 527 
for FOX-O3aSer253 phosphorylation (Figure 4C), which decreased at POST +1 h for both 528 






Figure 4. Protein degradation-related responses. Phosphorylation and total proteins levels 533 
of FOX-O1Ser256 (A, B respectively), FOX-O3a Ser253 (C, D respectively) and MuRF-1 (E) 534 
before (PRE) and after (POST) seven weeks of resistance training with either cold-water 535 
immersion (COLD) or passive control (CON) applied after each training session, as well as 1 536 
h and 48 h after single exercise bouts performed before (PRE +1 h, PRE +48 h) and after 537 
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(POST +1 h, POST +48 h) the training period (phosphorylated proteins only). Data shown 538 
are back-transformed individual participant values and geometric means.  539 
* = P < 0.05 vs. PRE, † = substantially greater change vs. COLD, § = substantially greater 540 




***INSERT FIGURE 4 ABOUT HERE*** 545 
 546 
 547 
Heat shock protein responses 548 
p-HSP27 Ser15 549 
There was no group × time interaction (P = 0.804) nor influence of training status (P = 0.110) 550 
for HSP27Ser15 phosphorylation (Figure 5A), which increased for both groups combined at 551 
PRE +1 h and POST +1 h (time main effect: P < 0.001, Table 3). The increase in HSP27Ser15 552 
phosphorylation at PRE +1 h was also greater for COLD vs. CON (Table 4). 553 
 554 
p-HSP27 Ser82 555 
There was no group × time interaction (P = 0.377) nor influence of training status (P = 0.354) 556 
for HSP27Ser82 phosphorylation (Figure 5C), which increased for both groups combined at 557 
PRE +1 h and POST +1 h (time main effect: P < 0.001, Table 3). 558 
 559 
p-αβ crystallin Ser59 560 
There was no group × time interaction (P = 0.900) nor influence of training status (P = 0.483) 561 
for αβ crystallinSer59 phosphorylation (Figure 5E), which increased for both groups combined 562 






Figure 5. Heat shock protein responses. Phosphorylation of HSP27Ser15 (A), HSP27Ser82 (C) 567 
and αβ crystallinSer59 (E), and total protein levels of HSP27 (B), HSP72 (D), and αβ crystallin 568 
(F) before (PRE) and after (POST) seven weeks of resistance training with either cold-water 569 
immersion (COLD) or passive control (CON) applied after each training session, as well as 1 570 
h and 48 h after single exercise bouts performed before (PRE +1 h, PRE +48 h) and after 571 
(POST +1 h, POST +48 h) the training period (phosphorylated proteins only). Data shown 572 
are back-transformed individual participant values and geometric means. 573 
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* = P < 0.05 vs. PRE, ‡ = substantial change vs. PRE. † = substantially greater change vs. 574 








Figure 6. Representative Western blot images for analysed phosphorylated proteins (A) and 583 
total protein content (B) before (PRE) and after (POST) seven weeks of resistance training 584 
with either cold-water immersion (COLD) or passive control (CON) applied after each 585 
training session, as well as 1 h and 48 h after single exercise bouts performed before (PRE +1 586 
h, PRE +48 h) and after (POST +1 h, POST +48 h) the training period. 587 
 588 
 589 
***INSERT FIGURE 6 ABOUT HERE***  590 
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6. Discussion 591 
This study provides novel insights on the influence of post-exercise CWI on adaptations to 592 
whole-body resistance training, and the potential underlying mechanisms in skeletal muscle. 593 
Repeated post-exercise CWI blunted the training-induced increase in type II muscle fiber 594 
CSA following seven weeks of resistance training, which coincided with attenuated post-595 
exercise mTORC1 signalling (i.e., rps6 phosphorylation) after the training period. Repeated 596 
post-exercise CWI also increased basal levels of protein degradation markers (e.g., FOX-O1 597 
protein content) in skeletal muscle after the training period. Taken together, these 598 
observations suggest CWI may shift post-exercise muscle protein balance towards reduced 599 
protein synthesis and increased breakdown, culminating in blunted muscle fiber hypertrophy. 600 
However, the negative influence of CWI on muscle fiber hypertrophy did not translate to 601 
impeded maximal strength development. These data further highlight the negative influence 602 
of post-exercise CWI on muscle fiber hypertrophy, and suggest post-exercise CWI should be 603 
avoided if muscle hypertrophy is desired. 604 
 605 
The findings that CWI attenuated post-exercise anabolic signalling responses to single 606 
resistance training sessions, together with blunted type II muscle hypertrophy, are in 607 
agreement with previous work (56). Roberts et al. (56) also reported an attenuated increase in 608 
vastus lateralis type II fiber size following resistance training coupled with post-exercise 609 
CWI compared with an active recovery. In a separate sub-study (56), these responses 610 
occurred alongside a blunted increase in p70S6K phosphorylation after the first training 611 
session (at both 2 and 24 hours post-exercise) and attenuated myonuclei accretion after the 612 
training period. This blunting of p70S6K phosphorylation did not, however, influence the 613 
phosphorylation response of rps6, a key downstream target of p70S6K (54), nor other key 614 
proteins that regulate MPS, such as 4E-BP1 (eIF4E binding protein 1) (56). In contrast to 615 
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these findings (56), we noted similar post-exercise p70S6K phosphorylation with CWI 616 
application compared with passive recovery, which was elevated for both conditions before 617 
(at +1 and +48 h) and after the training period (at +48 h), and instead saw blunted post-618 
exercise phosphorylation of rps6, a key downstream target of p70S6K, after the training 619 
period. 620 
 621 
A novel aspect of this study was assessment of post-exercise molecular responses to single 622 
resistance training sessions, combined with either CWI or passive recovery, both before and 623 
after the training intervention. This allowed insight into the potential modulation of any CWI-624 
mediated effects on post-exercise molecular responses following a training period. Using this 625 
approach, we observed blunted mTORC1 signalling (i.e., rps6 phosphorylation) for the CWI 626 
group compared with CON after (i.e., at both POST +1 h and POST +48 h), but not before, 627 
the training period. This observation highlights the discordance between molecular responses 628 
to exercise performed in untrained and trained states, and suggests the blunting of anabolic 629 
responses by CWI may be exacerbated with repeated sessions of resistance training. Since 630 
these responses coincided with the timepoint whereby attenuated type II muscle fiber CSA 631 
was observed, this suggests muscle growth may be even further compromised with longer 632 
period of resistance training and CWI. From a mechanistic perspective, the negative influence 633 
of CWI on post-exercise anabolic responses may be mediated by the influence of cold 634 
exposure and thermogenesis on energy metabolism. For example, enhanced thermogenesis 635 
and associated increases in myoplasmic AMP during cold exposure (64) may have influenced 636 
AMPK activity, which would potentially inhibit mTORC1 signalling (7). However, as direct 637 
measures of AMPK activity were unfortunately not possible in the present study, this 638 
mechanism remains speculative. Evidence of increased thermogenesis with CWI is perhaps 639 
further supported by the greater loss of fat mass experienced by the COLD group, which may 640 
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have resulted from a lower net energy balance (stimulated by shivering and non-shivering 641 
thermogenesis) (63) following each CWI session. 642 
 643 
Despite the blunted improvement in type II muscle fiber CSA seen following resistance 644 
training with CWI, we did not observe any influence of CWI in lower-body lean mass 645 
assessed via DXA. This apparent discordance may be explained by the limitations of each 646 
measurement as indices of changes in whole muscle size, and because changes in whole-647 
muscle size do not always reflect changes in muscle fiber CSA (44). The reliability and 648 
sensitivity of DXA-derived measures of lean mass is highly dependent on levels of hydration 649 
and prior exercise (43). Although we attempted to control for both of these factors, the 650 
sensitivity of DXA for detecting small changes in muscle size is relatively poor compared to 651 
more sophisticated imaging techniques, such as MRI (magnetic resonance imaging) (36) or 652 
CT (computed tomography) (14). Indeed, previous studies (56) have reported attenuated 653 
increases in thigh muscle volume following resistance training coupled with CWI when 654 
assessed via MRI, which was consistent with their observations of blunted muscle fiber size. 655 
We therefore cannot exclude the possibility that DXA was not sensitive enough to detect 656 
changes in whole-muscle size that may have been underpinned by the responses seen at the 657 
muscle fiber level. In addition to differences in the sensitivity of DXA-derived lean mass 658 
versus direct measurements of muscle fiber CSA, differences in the region-specificity of each 659 
measure may also explain the discordant responses observed. For example, DXA provides an 660 
estimate of lean mass in the entire lower extremities, whereas muscle biopsies can only 661 
reflect a specific site in the vastus lateralis. As hypertrophy of the quadriceps femoris 662 
musculature occurs heterogeneously following resistance training (17), these region-specific 663 
differences may explain the observation of increased muscle fiber size in the absence of 664 




Unlike previous work (56), attenuated muscle fiber hypertrophy with lower-body CWI did 667 
not occur alongside blunted maximal lower-body strength gain. Although muscle 668 
hypertrophy has traditionally been associated with muscle strength gain (40), recent work has 669 
questioned the role of training-induced muscle hypertrophy in improved maximal strength 670 
(11). From this perspective, any influence of CWI on muscle hypertrophy may have little 671 
influence on strength, particularly when assessed during complex, dynamic tasks. Since 672 
strength is a highly task-specific phenomenon (41), it is also possible our findings were 673 
influenced by the particular measure of strength chosen. Since the contribution of neural 674 
factors (i.e., learning and coordination) to strength gain is larger during higher-complexity 675 
tasks (58), any attenuation of muscle hypertrophy may have less influence on strength gain 676 
when assessed during higher- versus lower-complexity tasks. It is interesting to note the 677 
magnitude of attenuated strength gain with CWI application in a previous study (56) 678 
appeared greater when assessed during lower- versus higher-complexity strength tasks (i.e., 679 
1-RM leg extension vs. leg press). As we employed a relatively high-complexity task (1-RM 680 
leg press) as the only strength outcome measure, this may explain why we did not observe 681 
any influence of blunted hypertrophy on maximal strength gain. Nevertheless, our results are 682 
in agreement with others showing relatively weak relationships between training-induced 683 
muscle hypertrophy and strength (2, 12, 18), and suggest blunted muscle hypertrophy with 684 
application of CWI can occur without any influence on dynamic strength development. 685 
However, although we did not observe impaired 1-RM strength gains with CWI application, 686 
we did observe a blunting of peak force during the CMJ. While not directly assessed in this 687 
study, this finding aligns with previous observations of blunted improvement in rate of force 688 
development after resistance training with CWI application (56) and suggests improvement in 689 
force-generating capacity during rapid, dynamic movements may be compromized with CWI. 690 
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Since these tasks are likely more relevant to athletic performance situations compared with 691 
maximal strength per se, the influence of CWI on these variables warrants further attention. 692 
 693 
Another novel aspect of this study was analysis of molecular mediators of protein 694 
degradation following resistance training coupled with regular CWI. The transcription of 695 
muscle-specific E3 ubiquitin ligases that mediate protein degradation, including MuRF-1, is 696 
regulated by the FOX-O family of transcription factors (59). After training, we observed a 697 
greater basal increase in total FOX-O1 protein content with CWI, but no change in MuRF-1 698 
protein content for either group. We also noted discordant between-group FOX-O1 and FOX-699 
O3a phosphorylation responses to the single exercise sessions performed before and after the 700 
intervention period. For example, post-exercise phosphorylation of FOX-O3aSer253 was 701 
acutely decreased before the training period (at PRE +1 h) for both groups (although this was 702 
not statistically significant), yet FOX-O1Ser256 phosphorylation was unchanged. Conversely, 703 
post-exercise increases in FOX-O1Ser256 phosphorylation were attenuated following CWI at 704 
both +1 h and +48 after the training period, whereas there were little changes noted for FOX-705 
O3aSer253 phosphorylation (although pooled data showed a decrease at POST +1 h). Based 706 
solely on these discordant FOX-O1 and FOX-O3a phosphorylation responses, it is unclear 707 
whether CWI induced a shift towards increased protein degradation, although the increased 708 
basal FOX-O1 protein content after the training period provides support for this occurring 709 
with CWI. Nonetheless, although increases in markers of protein degradation may be seen as 710 
counteractive to muscle anabolism, these responses are in fact necessary to facilitate exercise-711 
induced skeletal muscle remodelling by removing damaged proteins and/or providing amino 712 
acid substrates for synthesising new proteins (70). Because it is difficult to infer the balance 713 
between skeletal muscle anabolism and catabolism from these data, the contribution of these 714 




The heat-shock family of proteins are important for cellular homeostasis, protein preservation 717 
and degradation (46), and play key roles in several processes involved in exercise 718 
adaptations. For example, HSP72 regulates mRNA elongation rate (35) and inhibits several 719 
steps involved in protein degradation (5, 16, 61, 79). HSP27 and αβ-crystallin also inhibit 720 
protein degradation pathways (1, 15, 71) and bind to cytoskeletal and myofibrillar proteins 721 
following muscle damaging exercise, where they are thought to stabilise disrupted elements 722 
and assist in regeneration and remodelling (34, 49). Our data suggested a single session of 723 
resistance exercise, performed before the training period, induced similar increases in 724 
HSP27Ser15 phosphorylation at PRE +1 h for both conditions, although this change was 725 
further enhanced for COLD (ES: 0.82; ±1.01). Similar post-exercise changes in HSP27Ser15 726 
phosphorylation were however noted between groups after the training period. A similar 727 
pattern of response was also observed for HSP27Ser82 phosphorylation, with robust increases 728 
during the early post-exercise period both before and after the intervention (i.e., at PRE +1 h 729 
and POST +1 h), which was also not different between groups. Basal levels of HSP27 protein 730 
were elevated after the training intervention for both groups, although this effect was greater 731 
for CON (ES: 0.94; ±0.82). Total protein levels of αβ-crystallin were similarly increased at 732 
POST for both groups, while similar effects of a single exercise session on p-αβ-crystallinSer59 733 
were observed for both groups both before and after training, although there was a more 734 
prolonged increased in p-αβ-crystallinSer59 before training for both CON and COLD. Taken 735 
together, these data suggest repeated CWI blunts the chronic, but not acute, HSP27 response 736 
to resistance exercise. These responses may have contributed to the blunted fiber hypertrophy 737 
for COLD, given these small HSPs appear to be important for muscle remodelling (34, 49). 738 
Moreover, while basal HSP72 protein levels were unchanged for CON, they were reduced 739 
(0.7-fold) for COLD (ES: 0.79; ±0.57). Since HSP72 inhibits protein degradation (5, 16, 61, 740 
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79) and promotes protein synthesis (35), the downregulation of HSP72 may have contributed 741 
to the blunted increase in muscle fiber size observed for COLD.  742 
While the present data suggest CWI application after individual resistance training sessions 743 
blunts muscle fiber hypertrophy (but not strength gain), these responses were observed in 744 
previously untrained individuals. It is unclear, therefore, whether similar findings would 745 
occur in resistance-trained individuals, whose relative improvements in both strength and 746 
muscle growth would likely be less compared with untrained individuals. Our data suggest 747 
that blunted muscle fiber hypertrophy with CWI may be mediated via modulation of 748 
molecular pathways regulating muscle protein synthesis and degradation. However, our 749 
findings do not elucidate the specific upstream factors directly influenced by CWI that 750 
mediated the observed effects on post-exercise molecular responses and muscle fiber 751 
hypertrophy. While a number of CWI-mediated factors could have influenced these responses 752 
(e.g., post-exercise inflammation, satellite cell activation, reactive oxygen species generation, 753 
hormonal responses, changes in muscle blood flow), none of these factors were measured in 754 
the present study.  It is possible that if the resistance training protocol were altered to 755 
exacerbate residual neuromuscular fatigue and potentially inflammation (e.g., by increasing 756 
the frequency and/or volume of training), CWI might have been beneficial for hastening 757 
recovery and maintaining training intensity, and therefore may have differentially influenced 758 
long-term adaptation. Higher frequencies and/or volumes of resistance training are more 759 
likely to be completed by more highly-trained individuals, further suggesting the applicability 760 
of the present findings to these populations may be limited.  761 
 762 
Conclusions 763 
The present study provides novel insights into the modulation of key adaptations to whole-764 
body resistance training combined with lower-body CWI. We provide additional evidence of 765 
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blunted muscle fiber hypertrophy following resistance training coupled with post-exercise 766 
CWI. We provide evidence that CWI attenuates post-exercise anabolic responses both before 767 
and after seven weeks of resistance training, and increases basal levels of protein degradation 768 
markers post-training. The observation that the CWI-mediated blunting of anabolic responses 769 
to single resistance exercise bouts persists after a period of training has implications for 770 
muscle growth following longer-term training periods when coupled with CWI. Importantly, 771 
the attenuation of muscle fiber hypertrophy with CWI did not impair maximal strength, 772 
which potentially reflects the discordance between training-induced changes in muscle mass 773 
and strength. Together, these data further highlight the ability of CWI to blunt resistance 774 
training-induced muscle growth, but not strength, and suggest avoidance of post-exercise 775 
CWI when muscle hypertrophy is a desired resistance training outcome.  776 
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9. Figure legends 1005 
Figure 1. Study overview. DXA, dual x-ray absorptiometry scan; BEP, ballistic exercise 1006 
performance (countermovement jump, squat jump, ballistic push-up) testing; 1-RM, one-1007 
repetition maximum (leg press and bench press) testing. 1008 
 1009 
Figure 2. Type I (A) and type II (B) muscle fiber cross-sectional area (CSA) before (PRE), 1010 
and after (POST) seven weeks of resistance training with either cold-water immersion 1011 
(COLD) or passive control (CON) applied after each training session. Data are mean values ± 1012 
SD. Representative confocal microscope immunofluorescence images of muscle cross-1013 
sections obtained before (PRE) and after (POST) seven weeks of resistance training with 1014 
application of either control (CON; images C and D, respectively) or cold-water immersion 1015 
(COLD; images E and F, respectively) or after each training session. Muscle fiber 1016 
membranes are visualized green, type I muscle fibers are visualized red, and type II muscle 1017 
fibers are unstained. Scale bar = 200 µm. † = Substantially greater change for CON vs. 1018 
COLD. 1019 
 1020 
Figure 3. mTORC1 signalling responses. Phosphorylation and total proteins levels of 1021 
p70S6KThr389 (A, B respectively), rps6Ser235/236 (C, D respectively), and 4E-BP1Thr36/47 (E, F 1022 
respectively) before (PRE) and after (POST) seven weeks of resistance training with either 1023 
cold-water immersion (COLD) or passive control (CON) applied after each training session, 1024 
as well as 1 h and 48 h after single exercise bouts performed before (PRE +1 h, PRE +48 h) 1025 
and after (POST +1 h, POST +48 h) the training period (phosphorylated proteins only). Data 1026 
shown are back-transformed individual participant values and geometric means. * = P < 0.05 1027 
vs. PRE, † = substantially greater change vs. COLD. 1028 
 1029 
Figure 4. Protein degradation-related responses. Phosphorylation and total proteins levels 1030 
of FOX-O1Ser256 (A, B respectively), FOX-O3a Ser253 (C, D respectively) and MuRF-1 (E) 1031 
before (PRE) and after (POST) seven weeks of resistance training with either cold-water 1032 
immersion (COLD) or passive control (CON) applied after each training session, as well as 1 1033 
h and 48 h after single exercise bouts performed before (PRE +1 h, PRE +48 h) and after 1034 
(POST +1 h, POST +48 h) the training period (phosphorylated proteins only). Data shown 1035 
are back-transformed individual participant values and geometric means. * = P < 0.05 vs. 1036 
PRE, † = substantially greater change vs. COLD, § = substantially greater change vs. CON. 1037 
 1038 
Figure 5. Heat shock protein responses. Phosphorylation of HSP27Ser15 (A), HSP27Ser82 (C) 1039 
and αβ crystallinSer59 (E), and total protein levels of HSP27 (B), HSP72 (D), and αβ crystallin 1040 
(F) before (PRE) and after (POST) seven weeks of resistance training with either cold-water 1041 
immersion (COLD) or passive control (CON) applied after each training session, as well as 1 1042 
h and 48 h after single exercise bouts performed before (PRE +1 h, PRE +48 h) and after 1043 
(POST +1 h, POST +48 h) the training period (phosphorylated proteins only). Data shown 1044 
are back-transformed individual participant values and geometric means. * = P < 0.05 vs. 1045 
46 
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Figure 6. Representative Western blot images for analysed phosphorylated proteins (A) and 1049 
total protein content (B) before (PRE) and after (POST) seven weeks of resistance training 1050 
with either cold-water immersion (COLD) or passive control (CON) applied after each 1051 
training session, as well as 1 h and 48 h after single exercise bouts performed before (PRE +1 1052 
h, PRE +48 h) and after (POST +1 h, POST +48 h) the training period. 1053 
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Table 1. Participant physical characteristics, exercise performance and body composition 
data for the control (CON) and cold water immersion (COLD) training groups. Data shown 
are group means ± SD. * = P < 0.05 vs. PRE. 
 
CON COLD  
PRE POST PRE POST 
Physical characteristics     
Age (y) 25.0 ± 4.9 - 20.9 ± 3.4 - 
Height (m) 1.84 ± 0.06 - 1.80 ± 0.08 - 
Body mass (kg) 88.5 ± 22.3 90.3 ± 22.5* 80.4 ± 10.7 81.2 ± 11 
Maximal strength     
1-RM leg press (kg) 338 ± 78 464 ± 111* 346 ± 55 480 ± 108* 
1-RM bench press (kg) 79.5 ± 17.2 86.4 ± 20.6* 75.6 ± 16 83.4 ± 14.5* 
Ballistic exercise performance     
CMJ peak force (N) 1850 ± 380 1948 ± 425*† 1908 ± 324 1846 ± 318 
Squat jump peak force (N) 1997 ± 451 2129 ± 495 2008 ± 372 1987 ± 323 
Ballistic push-up peak force (N) 881 ± 188 884 ± 176 855 ± 102 856 ± 74 
Body composition     
Upper-body lean mass (kg) 38.9 ± 7.0 40.8 ± 7.1* 36.3 ± 3.4 37.7 ± 4.0* 
Lower-body lean mass (kg) 21.6 ± 2.0  22.5 ± 3.3* 20.5 ± 2.1 21.4 ± 2.4* 
Total lean mass (kg) 60.6 ± 8.9 63.3 ± 10.3*  55.7 ± 5.3 59.1 ± 6.2* 
Body fat (%) 19.6 ± 12.4 18.5 ± 11.4* 15.6 ± 6.8 13.9 ± 6.7* 
 
Table 2. Details of the resistance training (RT) intervention performed by both the control 
(CON) and cold water immersion (COLD) groups.  
 
Session Exercise Sets x repetitions 
Session 1 Back squat 3 x 12 
 Barbell bench press 3 x 12 
 Lat pulldown 3 x 12 
 Walking lunges 3 x 12 each leg 
 Shoulder press 3 x 12 
 Dumbbell bicep curl 3 x 12 
 Tricep extension 3 x 12 
 Lying leg raise 3 x 12 
Session 2 45° Leg press 3 x 12 
 Dumbbell bench press 3 x 12 
 Bent-over row 3 x 12 
 Stiff-leg deadlift 3 x 12 
 Upright row 3 x 12 
 Barbell bicep curl 3 x 12 
 Tricep dips 3 x 20 
 Abdominal curls 3 x 20 
Session 3 45° Leg press 1-RM  
 Bench press 1-RM  
 Back squat 5 x 12 
 Barbell bench press 5 x 12 
 
Table 3. Summary of all within-group effects considered substantial in magnitude. 
Measure Group Change  between 
Mean change Standardised effect size (ES) 
Effect magnitude 
Absolute or 
fold change 90% CI ES (d) ±90% CI 
Performance measures      
1-RM leg press Pooled PRE-POST 130 kg ± 69 1.53 0.49 large 
        
1-RM bench press Pooled PRE-POST 7.3 kg ± 6.8 0.40 0.26 small 
        
Peak CMJ force CON PRE-POST 98 N ± 101 0.24 0.16 small 
        
Body composition      
Total lean mass Pooled PRE-POST 2.6 kg ± 1.9 0.31 0.14 small 
        
Upper-body lean mass Pooled PRE-POST 0.4 kg ± 0.3 0.36 0.18 small 
        
Lower-body lean mass Pooled PRE-POST 0.9 kg ± 1.2 0.37 0.27 small 
        
Fat mass Pooled PRE-POST -1.4 % ± 1.7 -0.13 0.11 trivial 
        
Total protein content      
Total rps6 protein Pooled PRE-POST 1.3-fold ×/÷ 1.2 1.13 1.25 moderate 
        
Total FOX-O1 protein Pooled PRE-POST 1.3-fold ×/÷ 1.3 1.62 1.75 large 
        
Total HSP27 protein Pooled PRE-POST 1.3-fold ×/÷ 1.2 0.85 0.60 moderate 
        
        
Measure Group Change  between 
Mean change Standardised effect size (ES) 
Effect magnitude 
Absolute or 
fold change 90% CI ES (d) ±90% CI 
Total HSP72 protein Pooled PRE-POST 0.8-fold ×/÷ 1.3 0.50 0.48 small 
 COLD PRE-POST -0.7-fold ×/÷ 1.2 -0.79 0.57 moderate 
        
Total αβ crystallin protein Pooled PRE-POST 1.2-fold ×/÷ 1.1 0.66 0.53 moderate 
        
Protein phosphorylation      
p-p70S6K Thr389  PRE-PRE+1 h 2.3-fold ×/÷ 2.1 1.29 1.13 large 
 Pooled PRE-PRE+48 h 2.1-fold ×/÷ 1.7 1.14 0.84 moderate 
  POST-POST+48 h 2.4-fold ×/÷ 2.6 0.77 0.84 moderate 
        
p-rps6 Ser235/236  PRE-PRE+1 h 4.7-fold ×/÷ 2.3 1.45 0.77 large 
 Pooled POST-POST+1 h 2.7-fold ×/÷ 2.9 1.77 0.84 large 
  POST-POST+48 h 2.6-fold ×/÷ 2.9 0.75 0.84 moderate 
        
p-FOX-O3a Ser253 Pooled POST-POST+1 h -0.5-fold ×/÷ 1.8 -0.9 0.8 moderate 
        
p-HSP27 Ser15 Pooled 
PRE-PRE+1 h 4.0-fold ×/÷ 1.7 2.3 0.9 very large 
 POST-POST+1 h 2.6-fold ×/÷ 1.5 2.1 0.8 very large 
        
p-HSP27 Ser82 Pooled 
PRE-PRE+1 h 4.4-fold ×/÷ 1.5 2.0 0.50 very large 
 POST-POST+1 h 4.5-fold ×/÷ 1.7 1.8 0.60 large 
        
p-αβ crystallin Ser59  PRE-PRE+1 h 3.0-fold ×/÷ 1.5 4.5 1.8 extremely large 
 Pooled PRE-PRE+48 h 1.3-fold ×/÷ 1.3 1.2 1.0 large 
  POST-POST+1 h 2.1-fold ×/÷ 1.4 2.2 1.1 very large 
        
 
Table 4. Summary of all between-group effects considered substantial in magnitude. 
Measure Group comparison 
Change  
between 
Mean difference in change Standardised effect size (ES) 
Effect 
magnitude 
Absolute or fold 
difference 90% CI ES (d) ±90% CI  
Performance measures      
Peak CMJ force CON vs. COLD PRE-POST 160 N ± 73 0.44 0.27 small 
        
Muscle fiber CSA      
Type II muscle fiber CSA CON vs. COLD PRE-POST 1915 µM2 ± 1675 1.37 0.99 large 
        
Total protein content      
Total FOX-O1 protein CON vs. COLD PRE-POST -1.3-fold ×/÷ 1.4 -2.17 2.22 very large 
        
Total HSP27 protein CON vs. COLD PRE-POST 0.8-fold ×/÷ 1.3 0.94 0.82 moderate 
        
Protein phosphorylation      
p-rps6 Ser235/236 CON vs. COLD POST-POST+1 h 0.4-fold ×/÷ 3.0 0.69 0.86 moderate 
  POST-POST+48 h 0.2-fold ×/÷ 2.9 1.33 0.82 large 
        
p-4E-BP1 Thr36/47 CON vs. COLD PRE-PRE+1 h 0.9-fold ×/÷ 1.2 0.40 0.45 small 
        
p-FOX-O1 Ser256 CON vs. COLD POST-POST+1 h 0.5-fold ×/÷ 2.1 1.03 1.11 moderate 
  POST-POST+48 h 0.5-fold ×/÷ 1.6 1.13 0.72 moderate 
        
p-HSP27 Ser15 CON vs. COLD PRE-PRE+1 h -1.6-fold ×/÷ 1.8 -0.82 1.01 moderate 
        
 
